RohitKKatialMD
Allergy & Immunology • Denver, COClinical & Laboratory Immunology
Professor of Medicine, National Jewish Health; University of Colorado
Dr. Katial is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 Jackson St
Denver, CO 80206Phone+1 303-388-4461Fax+1 303-270-2206
Education & Training
National Capital ConsortiumFellowship, Clinical and Laboratory Immunology, 1996 - 1997
Fitzsimons Army Medical CenterFellowship, Allergy and Immunology, 1994 - 1996
Dwight David Eisenhower Army Medical CenterResidency, Internal Medicine, 1991 - 1994
Georgetown University School of MedicineClass of 1991
Certifications & Licensure
CO State Medical License 2002 - 2025
VA State Medical License 1993 - 2004
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Top Doctors 5280 Magazine, 2012
- Fellow (FACP) American College of Physicians, 2000
- Join now to see all
Clinical Trials
- Sub-Sensitivity to Long-Acting Bronchodilators (LABA) Start of enrollment: 2010 Mar 01
- Long-acting Beta Agonist Step Down Study Start of enrollment: 2012 Mar 01
Publications & Presentations
PubMed
- Benralizumab in severe eosinophilic asthma by biologic use and key clinical subgroups: real-world XALOC-1 programme: a plain language summary of publication.David J Jackson, Girolamo Pelaia, Benjamin Emmanuel, Trung N Tran, David Cohen
Immunotherapy. 2025-02-11 - International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress Update.Désirée Larenas-Linnemann, Chin Kook Rhee, Alan Altraja, John Busby, Trung N Tran
Tuberculosis and Respiratory Diseases. 2025-02-06 - Disease Overlap, Healthcare Resource Utilization, and Costs in Patients with Eosinophilic Granulomatosis with Polyangiitis: A REVEAL Sub-study.Xiao Xu, Christopher Edmonds, YongJin Kim, Michael Stokes, Heide A Stirnadel-Farrant
Rheumatology and Therapy. 2024-12-01
Journal Articles
- Original Article Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal PolypsRohit K Katial, Margaret Garin, Steven F Weinstein, ScienceDirect
Lectures
- Clinical Communications zxcvbnUS Trends in Mortality Rates for Primary Immunodeficiency DiseasesAmerican College of Physicians, Albuquerque, New York - 10/25/2012
- Clinical Communications zxcvbnUS Trends in Mortality Rates for Primary Immunodeficiency DiseasesEastern Allergy Conference, Palm Beach, Florida - 5/30/2013
Press Mentions
Add-on Reslizumab Lowers Asthma Exacerbation Rates in Aspirin-Sensitive PatientsMarch 4th, 2017
CDC Wonders ‘Is It Really A Penicillin Allergy?’March 21st, 2016
High Ozone and Pollen Levels Could Worsen AllergiesMay 13th, 2015- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
